-
CDC Recommends Pfizer COVID-19 Booster for Children 5 to 11
The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.
-
Pfizer Hopes to Submit Little-Kid Vaccine Data by Early June
Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.
-
Biden Admin to Promote Availability of COVID Antiviral Pill
President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed
-
Pfizer Says COVID-19 Booster Raises Antibodies in Kids 5-11
Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.
-
Pfizer to Seek FDA Approval for COVID Booster in Kids Ages 5 to 11
Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds
-
COVID Second Booster: Here's What to Know About Who's Eligible, Who Can Wait
Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.
-
More Than 30 Companies to Start Making Pfizer's COVID Pill
The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill
-
Pfizer Asks US to Allow 4th COVID Vaccine Dose for Seniors
Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors
-
Pfizer Vaccine May Offer Little Protection Against Infection in Kids 5-11
However, the Pfizer shots still offered protection against serious illness from COVID, the researchers found.
-
Pfizer Pulls Request to FDA for COVID-19 Vaccine for Kids Under 5
Pfizer said it believes three doses “may provide a higher level of protection in this age group.”
-
COVID Shots for Kids Under 5 Delayed After FDA Reversal
The FDA said it will wait for data on how well a third shot works for the youngest age group. Pfizer said in a statement that it expected the data by early April.
-
Pfizer Requests Vaccine Authorization for Kids Under 5
Pfizer on Tuesday asked U.S. regulators to authorize extra-low doses of its COVID-19 vaccine for children under age 5.
-
Pfizer Asks FDA to Allow COVID-19 Vaccine for Kids Under 5
The nation’s 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus.
-
Pfizer COVID Vaccine For Kids Under 5 Could Be Available By End of February
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old.
-
Pfizer Testing Vaccine Targeting Omicron
Pfizer announced Tuesday it has launched a clinical trial to test an updated COVID-19 vaccine that targets the omicron variant.
-
Pfizer Begins Clinical Trial for Omicron-Specific COVID Vaccine
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant
-
Boosters Effective Against Severe Illness From Omicron, CDC Studies Show
Three new U.S. studies offer more evidence that the COVID-19 vaccines are standing up to the omicron variant, at least among people who have gotten booster shots
-
CDC Endorses COVID Boosters Starting at Age 12
Vaccines still offer strong protection against serious illness from any type of COVID-19, including the highly contagious omicron variant, especially after a booster.
-
CDC Shortens Waiting Period for Pfizer Booster
The Centers for Disease Control and Prevention updated guidelines for Pfizer COVID-19 boosters, shortening the time from second dose to booster to five months.
-
CDC Signs Off on Shorter 5-Month Pfizer Booster Interval
The CDC also recommended that kids ages 5 to 11 with moderately or severely weakened immune systems receive an additional dose 28 days after their second Pfizer shot